POTOČKOVÁ, Hana, Jiří DOHNAL and B. THOME-KROMER. Regulation of veterinary point-of-care testing in the European Union, the United States of America and Japan. REVUE SCIENTIFIQUE ET TECHNIQUE-OFFICE INTERNATIONAL DES EPIZOOTIES. Paris: OFFICE INT EPIZOOTIES, 2020, vol. 39, No 3, p. 699-709. ISSN 0253-1933. Available from: https://dx.doi.org/10.20506/rst.39.3.3171.
Other formats:   BibTeX LaTeX RIS
Basic information
Original name Regulation of veterinary point-of-care testing in the European Union, the United States of America and Japan
Authors POTOČKOVÁ, Hana (203 Czech Republic, guarantor, belonging to the institution), Jiří DOHNAL (203 Czech Republic, belonging to the institution) and B. THOME-KROMER.
Edition REVUE SCIENTIFIQUE ET TECHNIQUE-OFFICE INTERNATIONAL DES EPIZOOTIES, Paris, OFFICE INT EPIZOOTIES, 2020, 0253-1933.
Other information
Original language English
Type of outcome Article in a journal
Field of Study 30104 Pharmacology and pharmacy
Country of publisher France
Confidentiality degree is not subject to a state or trade secret
WWW URL
Impact factor Impact factor: 1.181
RIV identification code RIV/00216224:14160/20:00129819
Organization unit Faculty of Pharmacy
Doi http://dx.doi.org/10.20506/rst.39.3.3171
UT WoS 000770919000004
Keywords in English European Union; Japan; Point-of-care testing; Regulation; United States of America; Veterinary diagnostics
Tags rivok, ÚAF
Tags International impact, Reviewed
Changed by Changed by: JUDr. Sabina Krejčiříková, učo 383857. Changed: 3/8/2023 10:35.
Abstract
Point-of-care testing (POCT) is used to detect diseases and other conditions or to monitor therapeutic procedures. In veterinary medicine, POCT not only helps during the prevention, diagnosis and treatment of animal diseases but it also has a direct impact on human health by safeguarding food supplies and preventing zoonoses. Despite its importance, the regulation of the quality, safety and effectiveness of POCT products is rarely discussed. This review reveals that the level of regulatory surveillance of veterinary POCT products in the European Union (EU), the United States of America and Japan is strikingly different, ranging from no regulation (EU) to comprehensive regulation, which is comparable to the procedures for the regulation of human in vitro medical devices (Japan). Details about the licensing procedures in these three locations, discussion of their strengths and weaknesses, and suggestions for possible future development of the regulation of these products are also provided.
PrintDisplayed: 29/5/2024 23:02